EGFR and neoplasm: Both RPTP-κ and PTPN2 knockdown increase levels of p-EGFR/Y1173 and of p-ERKs [46, 47], indicating a tumor suppressor activity of these PTPs and/or a mitogenic function of EGFR/Y1173 phosphorylation.